Your Opinion Matters to me...lots of outrage lately about the cost of the EpiPen etc. CNBC anchors were really pressing Mylan about their price hike on this life-saving item not to mention the FDA's role and recent lack of approving generic drugs more often (and quickly) - to create competition and lower costs.

So from this perspective, who would be the better candidate to reign in the FDA and actually help to LOWER healthcare costs ? TIA